The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Alan R. Kristal

Corresponding Author: Alan R. Kristal

Cancer Prevention Program

Fred Hutchinson Cancer Research Center

1100 Fairview Avenue N

[email]@fhcrc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Corresponding Author: Alan R. Kristal, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N. 2011 - 2012
  • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. 1999 - 2010
  • Fred Hutchinson Cancer Research Center & University of Washington, Cancer Association Program, 1100 Fairview Avenue N., M4-B402 PO Box 19024, USA. 2007

References

  1. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Kristal, A.R., Till, C., Tangen, C.M., Goodman, P.J., Neuhouser, M.L., Stanczyk, F.Z., Chu, L.W., Patel, S.K., Thompson, I.M., Reichardt, J.K., Hoque, A., Platz, E.A., Figg, W.D., Van Bokhoven, A., Lippman, S.M., Hsing, A.W. Cancer Epidemiol. Biomarkers Prev. (2012) [Pubmed]
  2. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Kristal, A.R., Till, C., Platz, E.A., Song, X., King, I.B., Neuhouser, M.L., Ambrosone, C.B., Thompson, I.M. Cancer Epidemiol. Biomarkers Prev. (2011) [Pubmed]
  3. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Kristal, A.R., Arnold, K.B., Neuhouser, M.L., Goodman, P., Platz, E.A., Albanes, D., Thompson, I.M. Am. J. Epidemiol. (2010) [Pubmed]
  4. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Kristal, A.R., Price, D.K., Till, C., Schenk, J.M., Neuhouser, M.L., Ockers, S., Lin, D.W., Thompson, I.M., Figg, W.D. Prostate (2010) [Pubmed]
  5. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Kristal, A.R., Arnold, K.B., Schenk, J.M., Neuhouser, M.L., Goodman, P., Penson, D.F., Thompson, I.M. Am. J. Epidemiol. (2008) [Pubmed]
  6. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Kristal, A.R., Schenk, J.M., Song, Y., Arnold, K.B., Neuhouser, M.L., Goodman, P.J., Lin, D.W., Stanczyk, F.Z., Thompson, I.M. Am. J. Epidemiol. (2008) [Pubmed]
  7. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Kristal, A.R., Arnold, K.B., Schenk, J.M., Neuhouser, M.L., Weiss, N., Goodman, P., Antvelink, C.M., Penson, D.F., Thompson, I.M. J. Urol. (2007) [Pubmed]
  8. Obesity and prostate cancer mortality. Kristal, A.R., Gong, Z. Future. Oncology. (london,. England) (2007) [Pubmed]
  9. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Kristal, A.R., Chi, C., Tangen, C.M., Goodman, P.J., Etzioni, R., Thompson, I.M. Cancer (2006) [Pubmed]
  10. Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability. Kristal, A.R., King, I.B., Albanes, D., Pollak, M.N., Stanzyk, F.Z., Santella, R.M., Hoque, A. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  11. Directions for future epidemiological research in lycopene and prostate cancer risk. Kristal, A.R., Schenk, J.M. J. Nutr. (2005) [Pubmed]
  12. Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Kristal, A.R., Blount, P.L., Schenk, J.M., Sanchez, C.A., Rabinovitch, P.S., Odze, R.D., Standley, J., Vaughan, T.L., Reid, B.J. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  13. Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer. Kristal, A.R. J. Urol. (2004) [Pubmed]
  14. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Kristal, A.R., Lampe, J.W. Nutr. Cancer (2002) [Pubmed]
  15. Mediating factors in dietary change: understanding the impact of a worksite nutrition intervention. Kristal, A.R., Glanz, K., Tilley, B.C., Li, S. Health. Educ. Behav (2000) [Pubmed]
  16. A randomized trial of a tailored, self-help dietary intervention: the Puget Sound Eating Patterns study. Kristal, A.R., Curry, S.J., Shattuck, A.L., Feng, Z., Li, S. Prev. Med (2000) [Pubmed]
  17. Precision and bias of food frequency-based measures of fruit and vegetable intakes. Kristal, A.R., Vizenor, N.C., Patterson, R.E., Neuhouser, M.L., Shattuck, A.L., McLerran, D. Cancer Epidemiol. Biomarkers Prev. (2000) [Pubmed]
  18. Differences in fat-related dietary patterns between black, Hispanic and White women: results from the Women's Health Trial Feasibility Study in Minority Populations. Kristal, A.R., Shattuck, A.L., Patterson, R.E. Public. Health. Nutr (1999) [Pubmed]
 
WikiGenes - Universities